Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US
Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US
VY-AADC02
VY-AADC02 for Parkinson’s Disease With Motor Fluctuations
https://clinicaltrials.gov/ct2/show/NCT03562494?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F06%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
VY-AADC02 for Parkinson’s Disease With Motor Fluctuations
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Biological: VY-AADC02; Other: Placebo
Sponsors: Neurocrine Biosciences; Voyager Therapeutics
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03562494
FIRST POSTED:
Tue, 19 Jun 2018 12:00:00 EDT
LAST UPDATE POSTED:
05/20/19 07:34AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03562494?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F06%2F2019&lupd_d=14&sort=nwst